MannKind Corp. Target of Unusually High Options Trading (MNKD)
MannKind Corp. (NASDAQ:MNKD) was the recipient of some unusual options trading activity on Wednesday. Traders purchased 6,117 put options on the stock, Analyst Ratings Network.com reports. This represents an increase of approximately 138% compared to the typical daily volume of 2,568 put options.
In other MannKind Corp. news, VP Juergen Martens sold 32,054 shares of the stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $5.00, for a total transaction of $160,270.00. Following the completion of the sale, the vice president now directly owns 139,450 shares in the company, valued at approximately $697,250. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
MNKD has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of MannKind Corp. in a research note to investors on Monday. They now have a $5.50 price target on the stock. Separately, analysts at Piper Jaffray initiated coverage on shares of MannKind Corp. in a research note to investors on Tuesday, November 26th. They set a “neutral” rating and a $5.00 price target on the stock. Finally, analysts at MLV Capital cut their price target on shares of MannKind Corp. from $11.00 to $10.00 in a research note to investors on Wednesday, November 6th. They now have a “buy” rating on the stock. One analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $6.38.
Shares of MannKind Corp. (NASDAQ:MNKD) opened at 5.20 on Thursday. MannKind Corp. has a 1-year low of $2.32 and a 1-year high of $8.70. The stock has a 50-day moving average of $5.04 and a 200-day moving average of $5.90. The company’s market cap is $1.565 billion.
MannKind Corp. (NASDAQ:MNKD) last issued its quarterly earnings data on Monday, November 4th. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.14) by $0.03. During the same quarter in the prior year, the company posted ($0.22) earnings per share. The company’s quarterly revenue was down 100.0% on a year-over-year basis. Analysts expect that MannKind Corp. will post $-0.62 EPS for the current fiscal year.
MannKind Corporation (NASDAQ:MNKD) is a development-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.